SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-011901
Filing Date
2018-05-08
Accepted
2018-05-08 16:47:41
Documents
51
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20180331.htm 10-Q 1600740
2 EX-31.1 xene-ex311_7.htm EX-31.1 18931
3 EX-31.2 xene-ex312_8.htm EX-31.2 18994
4 EX-32.1 xene-ex321_9.htm EX-32.1 11659
5 EX-32.2 xene-ex322_6.htm EX-32.2 11296
  Complete submission text file 0001564590-18-011901.txt   4048121

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT xene-20180331.xml EX-101.INS 572208
7 XBRL TAXONOMY EXTENSION SCHEMA xene-20180331.xsd EX-101.SCH 34335
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xene-20180331_cal.xml EX-101.CAL 38102
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xene-20180331_def.xml EX-101.DEF 101469
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20180331_lab.xml EX-101.LAB 241473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20180331_pre.xml EX-101.PRE 184889
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 18815376
SIC: 2834 Pharmaceutical Preparations